Background: Febrile neutropenia (FN) is a common complication in children who receive chemotherapy for cancer.
Objective: The objective of this study was to evaluate the clinical efficacy of the continuous versus intermittent infusion of piperacillin/tazobactam (TZP) in febrile neutropenic pediatric patients.
Methods: This is a non-blinded randomized controlled clinical trial.
Background: Candida infections have increased in the last few decades. Previous colonization is the most important risk factor for the development of fungemia. Understanding local epidemiology is necessary in order to select the optimal anti-fungal treatment.
View Article and Find Full Text PDF